A number of investment brokers have recently updated their price targets on shares of athenahealth, Inc. (NASDAQ:ATHN). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

02/08/2016 – athenahealth, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 150 price target on the stock.

02/08/2016 – athenahealth, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 149 price target on the stock.

02/08/2016 – athenahealth, Inc. had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 162 price target on the stock.

02/08/2016 – athenahealth, Inc. was upgraded to “buy” by analysts at Topeka Capital Markets. They now have a USD 160 price target on the stock.

12/11/2015 – athenahealth, Inc. had its “hold” rating reiterated by analysts at Canaccord Genuity. They now have a USD 140 price target on the stock.

12/11/2015 – athenahealth, Inc. had its “underweight” rating reiterated by analysts at Barclays. They now have a USD 110 price target on the stock.

12/10/2015 – athenahealth, Inc. had its “market perform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 135 price target on the stock.

12/09/2015 – athenahealth, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank.

12/02/2015 – athenahealth, Inc. had its “sell” rating reiterated by analysts at Jefferies.

11/17/2015 – JP Morgan began new coverage on athenahealth, Inc. giving the company a “overweight” rating. They now have a USD 170 price target on the stock.

10/26/2015 – athenahealth, Inc. had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 175 price target on the stock.

10/26/2015 – athenahealth, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 185 price target on the stock.

10/26/2015 – athenahealth, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 190 price target on the stock.

10/26/2015 – athenahealth, Inc. had its “underperform” rating reiterated by analysts at RBC Capital. They now have a USD 105 price target on the stock.

10/21/2015 – athenahealth, Inc. had its “market perform” rating reiterated by analysts at Avondale Partners. They now have a USD 175 price target on the stock.

The share price of athenahealth, Inc. (NASDAQ:ATHN) was down -0.20% during the last day of trading, with a day high of 128.88. 261543 shares were traded during the last session.

The stock’s 50 day moving average is 135.78 and its 200 day moving average is 144.93. The stock’s market capitalization is 5.00B. athenahealth, Inc. has a 52-week low of 110.68 and a 52-week high of 170.42.

View other investors thoughts on athenahealth, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.